Biopharmaceuticals MCQs

Welcome to our comprehensive collection of Multiple Choice Questions (MCQs) on Biopharmaceuticals, a fundamental topic in the field of Drug and Pharmaceutical Biotechnology. Whether you're preparing for competitive exams, honing your problem-solving skills, or simply looking to enhance your abilities in this field, our Biopharmaceuticals MCQs are designed to help you grasp the core concepts and excel in solving problems.

In this section, you'll find a wide range of Biopharmaceuticals mcq questions that explore various aspects of Biopharmaceuticals problems. Each MCQ is crafted to challenge your understanding of Biopharmaceuticals principles, enabling you to refine your problem-solving techniques. Whether you're a student aiming to ace Drug and Pharmaceutical Biotechnology tests, a job seeker preparing for interviews, or someone simply interested in sharpening their skills, our Biopharmaceuticals MCQs are your pathway to success in mastering this essential Drug and Pharmaceutical Biotechnology topic.

Note: Each of the following question comes with multiple answer choices. Select the most appropriate option and test your understanding of Biopharmaceuticals. You can click on an option to test your knowledge before viewing the solution for a MCQ. Happy learning!

So, are you ready to put your Biopharmaceuticals knowledge to the test? Let's get started with our carefully curated MCQs!

Biopharmaceuticals MCQs | Page 12 of 13

Discover more Topics under Drug and Pharmaceutical Biotechnology

Q111.
Which polypeptide of cholera enterotoxin is nontoxic but immunogenic?
Discuss
Answer: (c).B
Q112.
What are the disadvantages of recombinant protein or polypeptide vaccines?
Discuss
Answer: (d).Cost, transportation, storage
Q113.
Who developed the first vaccine?
Discuss
Answer: (c).Jenner
Q114.
What causes smallpox?
Discuss
Answer: (b).Virus
Discuss
Answer: (d).Attenuated, inactivated, portions of protein, polysaccharides
Q116.
Which vaccine among these is used in its inactivated form?
Discuss
Answer: (a).Influenza
Discuss
Answer: (d).Molecular pathogenicity of the disease and the disease-causing organism
Discuss
Answer: (d).FDA- Food and Drug Administration
Q119.
The BCG vaccine was developed by ___________ and ____________
Discuss
Answer: (a).Albert Calmette and Camille Guérin
Q120.
A recombinant engineered vaccine is β€œdirect manipulation of genes of weakened or killed pathogen for stimulating antibody production or cellular immunity against the pathogen but is incapable of causing severe infection”.
Discuss
Answer: (a).True